Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
20.82
+0.35 (1.71%)
Aug 25, 2026, 4:00 PM EDT - Market closed
Sabra Health Care REIT Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Sabra Health Care REIT stock has a consensus rating of "Buy" and an average price target of $22.57. The average 1-year stock price forecast is 8.41% higher than the current stock price, while the lowest is $19 (-8.74%) and the highest is $25 (+20.08%).
Price Target: $22.57 (+8.41%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Sabra Health Care REIT stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 8 | 7 | 7 | 9 | 9 | 10 |
| Sell | 0 | 0 | 0 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 13 | 13 | 15 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $21 | Hold | Maintains | $21 | +0.86% | Aug 21, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 17, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $24 | Buy | Maintains | $24 | +15.27% | Aug 13, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $22 | Hold | Maintains | $22 | +5.67% | Aug 10, 2026 |
| Raymond James | Raymond James | Hold Upgrades $23 | Hold | Upgrades | $23 | +10.47% | Aug 6, 2026 |
Financial Forecast
Revenue This Year
922.05M
from 775.76M
Increased by 18.86%
Revenue Next Year
1.00B
from 922.05M
Increased by 8.87%
EPS This Year
0.67
EPS Next Year
0.78
from 0.67
Increased by 15.92%
EPS based on non-GAAP adjusted numbers.